Health News Releases

  • Today May 22
September 29, 2014 12:00
Oral OTEZLA® (apremilast) Approved by the U.S. Food and Drug Administration for the Treatment of Patients with Moderate to Severe Plaque Psoriasis
Celgene Corporation (NASDAQ: CELG) today announced that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast), the Company’s oral, selective inhibitor of phosphodiesterase 4 (P
September 26, 2014 11:15
22nd Century Group Granted Meeting with FDA to Advance Development of a Potential Modified Risk Cigarette
22nd Century Group, Inc. (NYSE MKT:XXII, http://finance.yahoo.com/q?s=xxii) announced today that the Center for Tobacco Products (“CTP”) of the U.S. Food and Drug Administration (“FDA”) has granted th
September 23, 2014 15:00
Merck to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry
Merck, a leading company for innovative and top-quality high-tech products in the pharmaceutical, chemical and life science sectors, and Sigma-Aldrich today announced that they have entered into a def
September 22, 2014 10:15
Boehringer Ingelheim and CureVac announce collaboration to develop next generation lung cancer immunotherapy
For Ex-US and Ex-UK Media Only Boehringer Ingelheim and CureVac, leader in mRNA (messenger ribonucleic acid)-based drug development, today jointly announce an exclusive global license and developme
September 19, 2014 14:30
MSD Presents First Phase 3 Data in Japanese Patients for Omarigliptin, an Investigational Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes
MSD, known as Merck & Co., Inc. (NYSE:MRK) in the United States and Canada, today announced the presentation of the first data from the Phase 3 clinical development program for omarigliptin, MSD’s inv
September 18, 2014 13:00
George Freeman, Minister for Life Sciences Unveils the Partnership between Synexus and the NHS
At a celebratory event at Chandos House, London last night Synexus shared details of the partnership between Synexus and Northumbria Healthcare NHS Foundation Trust which has seen them jointly open th
September 17, 2014 15:50
Bavarian Red Cross Selects LIFEPAK® Monitor/Defibrillators
Germany’s Rettungsdienst Bayern (www.rettungsdienst.brk.de) has announced that it will equip its emergency response fleets with monitor/defibrillators from Physio-Control. The ambulance service is one
September 17, 2014 15:20
Type 2 Diabetes: Investigational empagliflozin/linagliptin combination tablet shows sustained reduction in blood glucose in Phase III study
Boehringer Ingelheim and Eli Lilly and Company today presented results from a 52-week Phase III study that demonstrated sustained efficacy of the investigational empagliflozin/linagliptin combination
September 17, 2014 13:45
Endocrine Technology, L.L.C. Develops Most Advanced Technology for Ebola Health Crisis
Endocrine Technology, L.L.C. is a New York-based biotechnology company detailed at www.etbondusa.com. Kumar Shah, M.D., President of the company, brings the most advanced technology to solve the ebola
September 16, 2014 18:25
Covidien Announces Start of Enrollment in Two Neurovascular Clinical Trials
Covidien plc (www.covidien.com) announced today the start of enrollment in two clinical trials designed to further underscore the safety and effectiveness of the company’s advanced neurovascular solut
September 12, 2014 15:20
Pathway Genomics Launches BreastTrue NGS High Risk Breast Cancer Panel with PALB2
Pathway Genomics Corporation (www.pathway.com), a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, today announced it has launched BreastTrueT
September 11, 2014 17:30
Cordis Corporation Launches INCRAFT® AAA Stent Graft System for Treatment of Abdominal Aortic Aneurysms (AAA)
Cordis Corporation announced today the launch of its INCRAFT® AAA Stent Graft System (INCRAFT® System), an ultra-low profile device for use during endovascular aneurysm repair (EVAR) for patients suff
September 10, 2014 18:25
Diabetes: Boehringer Ingelheim and Eli Lilly and Company announce data on portfolio to be presented at the 50th EASD Annual Meeting
Data to be presented at the European Association for the Study of Diabetes (EASD) Annual Meeting in Vienna, Austria, will add to the extensive clinical evidence supporting the efficacy and safety prof
September 10, 2014 18:10
Nintedanib* slowed disease progression in IPF independent of patients’ lung function impairment at baseline
For media outside UK, US and Canada A pre-specified subgroup analysis from the two replicate Phase III INPULSIS™ trials, presented today at the European Respiratory Society International Congress (
September 10, 2014 17:25
TONADO™ - further lung function and quality of life benefits with tiotropium + olodaterol Respimat® FDC* in COPD
For media outside the US, the UK and Canada Data from the pivotal phase III TONADO™ studies†,1 for tiotropium + olodaterol Respimat® FDC were presented for the first time today at the European Resp
September 10, 2014 17:15
Asthma: new indication for Spiriva® (tiotropium) Respimat®* in the EU may offer millions of adults a significant advance in asthma care
For media outside the US, the UK & Canada only Boehringer Ingelheim today announced that the indication for Spiriva® (tiotropium) Respimat®* in asthma has been accepted by the regulatory authoritie
September 04, 2014 13:45
KCI, LifeCell and Systagenix Combine to Form One Company and Rebrand as Acelity
Centaur Guernsey L.P. Inc. (Centaur) announced today the launch of Acelity, effectively rebranding itself and its subsidiaries Kinetic Concepts, Inc. (KCI), LifeCell Corporation (LifeCell) and Systage
September 03, 2014 10:35
ESC Congress 2014 Hot Line Session: Favourable effect of Pradaxa® on kidney function over time compared to warfarin
Non-US/Non-UK/Non-Canadian Media New data presented today indicate that kidney function decline is less pronounced in patients with an irregular heartbeat (non-valvular atrial fibrillation, NVAF) w
September 02, 2014 09:10
Extensive experience in clinical practice and expanding research programme support use of Pradaxa® for clot prevention
For Non-US/Non-UK/Non-Canadian Media Five years on from the first breakthrough presentation of the pivotal RE-LY® clinical trial of Pradaxa® (dabigatran etexilate) for the prevention of stroke in n
September 01, 2014 17:05
Boehringer Ingelheim to present comprehensive data supporting broad respiratory portfolio in COPD, asthma and IPF at ERS 2014
For media outside UK, US and Canada The European Respiratory Society (ERS) International Congress, in Munich, Germany, September 6-10, 2014 sets the scene for important announcements across the sub
August 29, 2014 09:00
The International Bio-Community Meets in Japan! Announcing Integrated Biotech Business Event - BioJapan 2014
BioJapan 2014 - World Business Forum - will be held for three days from October 15th (Wed.) to 17th (Fri.), 2014 at Pacifico Yokohama (Exhibition Halls C & D, and Annex Hall). Comprised of exhibiti
August 27, 2014 16:00
New HeartSine AED Provides Automatic Shock Delivery
HeartSine® Technologies is pleased to announce the arrival of the samaritan® PAD 360P, a fully automatic AED (Automatic External Defibrillator) based on the company’s popular samaritan PAD 350P. Th
August 26, 2014 13:55
Centaur Announces CFO Transition Plan
Centaur Guernsey L.P. Inc. (Centaur) today announced that Robert Hureau, Executive Vice President and Chief Financial Officer for Centaur and each of its operating subsidiaries Kinetic Concepts, Inc.,
August 25, 2014 17:35
New Pradaxa® data to be presented at the ESC Congress 2014
For Non-US/Non-UK/Non-Canadian Media New Pradaxa® (dabigatran etexilate) data for the treatment of a broad range of thromboembolic diseases will be presented at the ESC Congress 2014, 30th August -
August 21, 2014 21:00
Project Data Sphere, LLC Appoints Dr. Kald Abdallah, Chief Project Data Sphere Officer
Project Data Sphere, LLC has appointed Kald Abdallah, MD, PhD as Chief Project Data Sphere Officer, charging him with continuing the rapid development of www.ProjectDataSphere.org which is providing b
25 per page50 per page75 per page100 per page